SEC Form 4 · accession 0000899243-16-027716
SOLENO THERAPEUTICS INC · SLNO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David D O'Toole
Officer — See Remarks
Period of report
Aug 18, 2016
Accepted (ET)
Aug 19, 2016 · 4:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001484565
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 18, 2016 | P | 2,000 | $1.01 | A | 44,750 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
Senior Vice President and Chief Financial Officer